Activation of the endothelial innate immune pathways of TLR2 and TLR4 is known to modulate pathways involved in endothelial permeability and coagulation that are associated with the initiation and progress of atherosclerosis, as well as with acute atherothrombotic adverse events [26,27,51,52]. Here, TLR2 is linked to atherosclerosis.